Profile
International Journal of Gynecology & Clinical Practices Volume 5 (2018), Article ID 4:IJGCP-139, 3 pages
http://dx.doi.org/10.15344/2394-4986/2018/139
Case Report
Special Issue: Gynecology & Surgical Oncology
Cervical Cancer at a Young Age: Considering Fanconi Anemia as Part of the Clinical Workup

Greta Weaver, Amanda Bruegl, Tanja Pejovic* and Melissa Moffitt

Department of Gynecologic Oncology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA
Dr. Tanja Pejovic, Department of Gynecologic Oncology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA, Tel: 503-418-9382, Fax: 503-418-4048; E-mail: pejovict@ohsu.edu
11 June 2018; 02 August 2018; 04 August 2018
Weaver G, Bruegl A, Pejovic T, Moffitt M (2018) Cervical Cancer at a Young Age: Considering Fanconi Anemia as Part of the Clinical Workup. Int J Gynecol Clin Pract 5: 139. doi: http://dx.doi.org/10.15344/2394-4986/2018/139

References

  1. Cancer of the Cervix Uteri - Cancer Stat Facts
  2. Young N (2012) Aplastic anemia, Myelodysplasia and related bone marrow failure syndromes. In: Longo DL, ed. Harrison’s Principles of International Medicine 1: 887
  3. Ntekim A, Campbell O, Rothenbacher D (2015) Optimal management of cervical cancer in HIV-positive patients: a systematic review. Cancer Med 4: 1381-1393 [CrossRef] [Google Scholar] [PubMed]
  4. Mathew CG (2006) Fanconi anaemia genes and susceptibility to cancer. Oncogene 25: 5875-5884 [CrossRef] [Google Scholar] [PubMed]
  5. Kim H, D’Andrea AD (2012) Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 26: 1393-1408 [CrossRef] [Google Scholar] [PubMed]
  6. Reference GH (2017) Fanconi anemia. Genetics Home Reference
  7. Sirák I, Šinkorová Z, Šenkeříková M, Špaček J, Laco J, et al. (2015) Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature. Rep Pract Oncol Radiother 20: 309-315 [CrossRef] [Google Scholar] [PubMed]
  8. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer
  9. Townsley DM, Dumitriu B, Liu D (2016) Danazol Treatment for Telomere Diseases. N Engl J Med 374: 1922-1931 [CrossRef] [Google Scholar] [PubMed]
  10. Gao G, Smith DI (2017) Human Papillomavirus and the Development of Different Cancers. Cytogenet Genome Res 150: 185-193 [CrossRef] [Google Scholar] [PubMed]
  11. Kee Y, D’Andrea AD (2012) Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest 122: 3799-3806 [CrossRef] [Google Scholar] [PubMed]
  12. Park S, Park JW, Pitot HC, Lambert PF (2016) Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice. MBio 7: 00628 [CrossRef] [Google Scholar] [PubMed]
  13. Alter BP, Giri N, Pan Y, Savage SA, Pinto LA, et al. (2014) Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes. Vaccine 32: 1169-1173 [CrossRef] [Google Scholar] [PubMed]
  14. HPV Vaccine Recommendations (2017) Human Papillomavirus. CDC